相似文献
1
Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario.
Arthritis Res Ther. 2009;11(1):103. doi: 10.1186/ar2576. Epub 2009 Jan 23.
2
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
3
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Arthritis Rheum. 2007 May;56(5):1676-84. doi: 10.1002/art.22580.
4
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study.
Rheumatology (Oxford). 2009 Dec;48(12):1537-40. doi: 10.1093/rheumatology/kep284. Epub 2009 Sep 23.
5
Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Ann N Y Acad Sci. 2007 Sep;1110:271-84. doi: 10.1196/annals.1423.029.
6
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
Med Decis Making. 2008 Nov-Dec;28(6):926-37. doi: 10.1177/0272989X08317015. Epub 2008 Apr 28.
7
Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
Clin Rheumatol. 2021 Aug;40(8):3185-3193. doi: 10.1007/s10067-021-05794-5. Epub 2021 Jun 2.
8
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
Arthritis Res Ther. 2016 Jun 2;18(1):123. doi: 10.1186/s13075-016-1015-0.
9
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.
J Dermatol. 2019 Nov;46(11):1006-1013. doi: 10.1111/1346-8138.15079. Epub 2019 Sep 9.
10
Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FAST.
Curr Rheumatol Rep. 2007 May;9(2):144-50. doi: 10.1007/s11926-007-0009-y.
本文引用的文献
1
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.
Arthritis Res Ther. 2008;10(5):R124. doi: 10.1186/ar2534. Epub 2008 Oct 20.
2
High-resolution computed tomography and scleroderma lung disease.
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v59-61. doi: 10.1093/rheumatology/ken271.
3
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
Med Decis Making. 2008 Nov-Dec;28(6):926-37. doi: 10.1177/0272989X08317015. Epub 2008 Apr 28.
4
Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Arthritis Rheum. 2007 Dec;56(12):4195-202. doi: 10.1002/art.23077.
5
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34. doi: 10.1164/rccm.200702-326OC. Epub 2007 Aug 23.
6
David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):169-71.
7
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Arthritis Rheum. 2007 May;56(5):1676-84. doi: 10.1002/art.22580.
8
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Arthritis Rheum. 2006 Dec;54(12):3962-70. doi: 10.1002/art.22204.
9
Cyclophosphamide versus placebo in scleroderma lung disease.
N Engl J Med. 2006 Jun 22;354(25):2655-66. doi: 10.1056/NEJMoa055120.
10
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis.
Clin Rheumatol. 2006 Mar;25(2):205-12. doi: 10.1007/s10067-005-1157-y. Epub 2005 Oct 14.
Zotero 插件